{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:01:59Z","timestamp":1780466519947,"version":"3.54.1"},"reference-count":55,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"abstract":"<jats:p>Objective. In an effort to reduce the occurrence of neural tube defects (NTDs), folic acid fortification of US enriched grain products was authorized by the Food and Drug Administration in March 1996 and required by January 1998. Fortification has been shown to result in an important decline in the prevalence of spina bifida and anencephaly in the general US population; however, fortification's impact on specific racial\/ethnic groups has not been well described. We sought to characterize the decline in the prevalence of spina bifida and anencephaly among specific racial\/ethnic groups during the transition to mandatory folic acid fortification in the United States.<\/jats:p><jats:p>Methods. Data from 21 population-based birth defects surveillance systems were used to examine trends in prevalence of spina bifida and anencephaly for specific racial\/ethnic groups for the years 1995\u20132002. These years were divided into 3 periods: prefortification, optional fortification, and mandatory fortification. Race\/ethnicity was defined as Hispanic, non-Hispanic white, and non-Hispanic black. Prevalence ratios were calculated for each racial\/ethnic group by dividing the prevalence from the mandatory fortification period by the prevalence in the prefortification period.<\/jats:p><jats:p>Results. The study included data on 4468 cases of spina bifida and 2625 cases of anencephaly. The prevalence of spina bifida and anencephaly was highest among Hispanic births, followed by non-Hispanic white births, with the lowest prevalence among non-Hispanic black births. Significant declines in spina bifida and anencephaly were observed among Hispanic births and non-Hispanic white births. The prevalence ratio for non-Hispanic black births was of borderline significance for spina bifida and was not significant for anencephaly.<\/jats:p><jats:p>Conclusions. The results of this study suggest that folic acid fortification is associated with significant decreases in the prevalence of spina bifida and anencephaly among non-Hispanic white and Hispanic births. The magnitude of the reduction was similar between these 2 groups and was more pronounced for spina bifida than for anencephaly. The decline in the prevalence of spina bifida and anencephaly among non-Hispanic black births did not reach statistical significance. Efforts to increase folic acid consumption for the prevention of NTDs in pregnancies among women of all races\/ethnicities should be continued, and studies to identify and elucidate other risk factors for NTDs are warranted.<\/jats:p>","DOI":"10.1542\/peds.2005-0592","type":"journal-article","created":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:36:02Z","timestamp":1125534962000},"page":"580-586","source":"Crossref","is-referenced-by-count":255,"title":["Decline in the Prevalence of Spina Bifida and Anencephaly by Race\/Ethnicity: 1995\u20132002"],"prefix":"10.1542","volume":"116","author":[{"given":"Laura J.","family":"Williams","sequence":"first","affiliation":[{"name":"National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Flores","sequence":"additional","affiliation":[{"name":"National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell S.","family":"Kirby","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, School of Public Health, University of Alabama, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry D.","family":"Edmonds","sequence":"additional","affiliation":[{"name":"National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,9,1]]},"reference":[{"key":"2021120820051287600_R1","unstructured":"Centers for Disease Control and Prevention. Spina bifida and anencephaly before and after folic acid mandate\u2013United States, 1995\u20131996 and 1999\u20132000. MMWR Morb Mortal Wkly Rep.\u20082004;53:362\u2013365"},{"key":"2021120820051287600_R2","doi-asserted-by":"crossref","unstructured":"Hendricks KA, Simpson JS, Larsen RD. Neural tube defects along the Texas-Mexico border, 1993\u20131995. Am J Epidemiol.\u20081999;149:1119\u20131127","DOI":"10.1093\/oxfordjournals.aje.a009766"},{"key":"2021120820051287600_R3","unstructured":"Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis\u2013United States, 1985\u20131994. MMWR Morb Mortal Wkly Rep.\u20081995;44:1\u201313"},{"key":"2021120820051287600_R4","doi-asserted-by":"crossref","unstructured":"Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F. Hispanic origin and neural tube defects in Houston\/Harris County, Texas. I. Descriptive epidemiology. Am J Epidemiol.\u20081996;143:1\u201311","DOI":"10.1093\/oxfordjournals.aje.a008647"},{"key":"2021120820051287600_R5","doi-asserted-by":"crossref","unstructured":"Feldman JG, Stein SC, Klein RJ, Kohl S, Casey G. The prevalence of neural tube defects among ethnic groups in Brooklyn, New York. J Chron Dis.\u20081982;35:53\u201360","DOI":"10.1016\/0021-9681(82)90029-7"},{"key":"2021120820051287600_R6","doi-asserted-by":"crossref","unstructured":"Feuchtbaum LB, Currier RJ, Riggle S, Roberson M, Lorey FW, Cunningham GC. Neural tube defect prevalence in California (1990\u20131994): eliciting patterns by type of defect and maternal race\/ethnicity. Genet Test.\u20081999;3:265\u2013272","DOI":"10.1089\/109065799316572"},{"key":"2021120820051287600_R7","doi-asserted-by":"crossref","unstructured":"Elwood JM, Little J, Elwood JH. Epidemiology and Control of Neural Tube Defects. Oxford, England: Oxford University Press; 1992","DOI":"10.1093\/oso\/9780192618849.001.0001"},{"key":"2021120820051287600_R8","doi-asserted-by":"crossref","unstructured":"Carmichael SL, Shaw GM, Kaidarova Z. Congenital malformations in offspring of Hispanic and African-American women in California, 1989\u20131997. Birth Defects Res A Clin Mol Teratol.\u20082004;70:382\u2013388","DOI":"10.1002\/bdra.20012"},{"key":"2021120820051287600_R9","doi-asserted-by":"crossref","unstructured":"Kirby R, Petrini J, Alter C. Collecting and interpreting birth defects surveillance data by Hispanic ethnicity: a comparative study. The Hispanic Ethnicity Birth Defects Workgroup. Teratology.\u20082000;61:21\u201327","DOI":"10.1002\/(SICI)1096-9926(200001\/02)61:1\/2<21::AID-TERA5>3.0.CO;2-X"},{"key":"2021120820051287600_R10","doi-asserted-by":"crossref","unstructured":"Ray JG, Vermeulen RJ, Meier C, Cole DE, Wyatt PR. Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ.\u20082004;171:343\u2013345","DOI":"10.1503\/cmaj.1040254"},{"key":"2021120820051287600_R11","doi-asserted-by":"crossref","unstructured":"Shaw GM, Velie EM, Wasserman CR. Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. Am J Public Health.\u20081997;87:1467\u20131471","DOI":"10.2105\/AJPH.87.9.1467"},{"key":"2021120820051287600_R12","unstructured":"Centers for Disease Control and Prevention. Spina bifida incidence at birth\u2013United States, 1983\u20131990. MMWR Morb Mortal Wkly Rep.\u20081992;41:497\u2013500"},{"key":"2021120820051287600_R13","doi-asserted-by":"crossref","unstructured":"Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med.\u20081992;327:1832\u20131835","DOI":"10.1056\/NEJM199212243272602"},{"key":"2021120820051287600_R14","doi-asserted-by":"crossref","unstructured":"Medical Research Council. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet.\u20081991;338:131\u2013137","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"2021120820051287600_R15","doi-asserted-by":"crossref","unstructured":"Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med.\u20081999;341:1485\u20131490","DOI":"10.1056\/NEJM199911113412001"},{"key":"2021120820051287600_R16","unstructured":"Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Reg.\u20081996;61:8781\u20138797"},{"key":"2021120820051287600_R17","doi-asserted-by":"crossref","unstructured":"Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology.\u20082002;66:33\u201339","DOI":"10.1002\/tera.10060"},{"key":"2021120820051287600_R18","doi-asserted-by":"crossref","unstructured":"Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA.\u20082001;285:2981\u20132986","DOI":"10.1001\/jama.285.23.2981"},{"key":"2021120820051287600_R19","doi-asserted-by":"crossref","unstructured":"Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med.\u20081999;341:1509\u20131519","DOI":"10.1056\/NEJM199911113412006"},{"key":"2021120820051287600_R20","unstructured":"Centers for Disease Control and Prevention. Statistical Analysis Battery for Epidemiological Research (SABER). Available at: www.cdc.gov\/nceh\/publications\/saber\/saber.htm. Accessed August 20, 2004"},{"key":"2021120820051287600_R21","doi-asserted-by":"crossref","unstructured":"Siega-Riz AM, Bodnar LM, Savitz DA. What are pregnant women eating? Nutrient and food group differences by race. Am J Obstet Gynecol.\u20082002;186:480\u2013486","DOI":"10.1067\/mob.2002.121078"},{"key":"2021120820051287600_R22","doi-asserted-by":"crossref","unstructured":"Jasti S, Siega-Riz AM, Bentley ME. Dietary supplement use in the context of health disparities: cultural, ethnic and demographic determinants of use. J Nutr.\u20082003;133:2010S\u20132013S","DOI":"10.1093\/jn\/133.6.2010S"},{"key":"2021120820051287600_R23","unstructured":"Ford ES, Ballew C. Dietary folate intake in US adults: findings from the third National Health and Nutrition Examination Survey. Ethn Dis.\u20081998;8:299\u2013305"},{"key":"2021120820051287600_R24","doi-asserted-by":"crossref","unstructured":"Timbo B, Altekruse S, Hyman F, Klontz K, Tollefson L. Vitamin and mineral supplementation during pregnancy. Mil Med.\u20081994;159:654\u2013658","DOI":"10.1093\/milmed\/159.10.654"},{"key":"2021120820051287600_R25","unstructured":"Canfield MA, Anderson JL, Waller DK, Palmer SE, Kaye CI. Folic acid awareness and use among women with a history of neural tube defect pregnancy\u2013Texas, 2000\u20132001. MMWR Morb Mortal Wkly Rep.\u20082002;51:16\u201319"},{"key":"2021120820051287600_R26","doi-asserted-by":"crossref","unstructured":"Ahluwalia IB, Lyon Daniel K. Are women with recent live births aware of the benefits of folic acid?MMWR Morb Mortal Wkly Rep.\u20082001;50:3\u201314","DOI":"10.1037\/e548292006-003"},{"key":"2021120820051287600_R27","doi-asserted-by":"crossref","unstructured":"Perlow JH. Comparative use and knowledge of preconceptional folic acid among Spanish- and English-speaking patient populations in Phoenix and Yuma, Arizona. Am J Obstet Gynecol.\u20082001;184:1263\u20131266","DOI":"10.1067\/mob.2001.112974"},{"key":"2021120820051287600_R28","doi-asserted-by":"crossref","unstructured":"Siega-Riz AM, Popkin BM, Carson T. Differences in food patterns at breakfast by sociodemographic characteristics among a nationally representative sample of adults in the United States. Prev Med.\u20082000;30:415\u2013424","DOI":"10.1006\/pmed.2000.0651"},{"key":"2021120820051287600_R29","doi-asserted-by":"crossref","unstructured":"Dary O. Lessons learned with iron fortification in Central America. Nutr Rev.\u20082002;60:S30\u2013S33","DOI":"10.1301\/002966402320285074"},{"key":"2021120820051287600_R30","unstructured":"Centers for Disease Control and Prevention. Folate status in women of childbearing age, by race\/ethnicity\u2013United States, 1999\u20132000. MMWR Morb Mortal Wkly Rep.\u20082002;51:808\u2013810"},{"key":"2021120820051287600_R31","doi-asserted-by":"crossref","unstructured":"Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol.\u20082000;151:862\u2013877","DOI":"10.1093\/oxfordjournals.aje.a010290"},{"key":"2021120820051287600_R32","doi-asserted-by":"crossref","unstructured":"Esfahani ST, Cogger EA, Caudill MA. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc.\u20082003;103:200\u2013207","DOI":"10.1053\/jada.2003.50030"},{"key":"2021120820051287600_R33","doi-asserted-by":"crossref","unstructured":"Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C&gt;T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet.\u20082003;40:619\u2013625","DOI":"10.1136\/jmg.40.8.619"},{"key":"2021120820051287600_R34","doi-asserted-by":"crossref","unstructured":"Barber R, Shalat S, Hendricks K, et al. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas Hispanic population. Mol Genet Metab.\u20082000;70:45\u201352","DOI":"10.1006\/mgme.2000.2991"},{"key":"2021120820051287600_R35","doi-asserted-by":"crossref","unstructured":"O'Leary VB, Mills JL, Kirke PN, et al. Analysis of the human folate receptor beta gene for an association with neural tube defects. Mol Genet Metab.\u20082003;79:129\u2013133","DOI":"10.1016\/S1096-7192(03)00075-1"},{"key":"2021120820051287600_R36","doi-asserted-by":"crossref","unstructured":"Zhu H, Junker WM, Finnell RH, et al. Lack of association between ZIC2 and ZIC3 genes and the risk of neural tube defects (NTDs) in Hispanic populations. Am J Med Genet.\u20082003;116A:414\u2013415","DOI":"10.1002\/ajmg.a.10032"},{"key":"2021120820051287600_R37","doi-asserted-by":"crossref","unstructured":"Zhu H, Wicker NJ, Volcik K, et al. Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects. Mol Genet Metab.\u20082004;81:127\u2013132","DOI":"10.1016\/j.ymgme.2003.11.003"},{"key":"2021120820051287600_R38","doi-asserted-by":"crossref","unstructured":"Volcik KA, Zhu H, Finnell RH, Shaw GM, Canfield M, Lammer EJ. Evaluation of the jumonji gene and risk for spina bifida and congenital heart defects. Am J Med Genet.\u20082004;126A:215\u2013217","DOI":"10.1002\/ajmg.a.20574"},{"key":"2021120820051287600_R39","doi-asserted-by":"crossref","unstructured":"Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics.\u20081990;85:1\u20139","DOI":"10.1542\/peds.85.1.1"},{"key":"2021120820051287600_R40","doi-asserted-by":"crossref","unstructured":"Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics.\u20082003;111:1152\u20131158","DOI":"10.1542\/peds.111.S1.1152"},{"key":"2021120820051287600_R41","doi-asserted-by":"crossref","unstructured":"Suarez L, Hendricks K, Felkner M, Gunter E. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol.\u20082003;13:81\u201388","DOI":"10.1016\/S1047-2797(02)00267-3"},{"key":"2021120820051287600_R42","doi-asserted-by":"crossref","unstructured":"Ray JG, Blom HJ. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM.\u20082003;96:289\u2013295","DOI":"10.1093\/qjmed\/hcg043"},{"key":"2021120820051287600_R43","doi-asserted-by":"crossref","unstructured":"Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999\u20132002. JAMA.\u20082004;291:2847\u20132850","DOI":"10.1001\/jama.291.23.2847"},{"key":"2021120820051287600_R44","doi-asserted-by":"crossref","unstructured":"Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA.\u20082003;289:76\u201379","DOI":"10.1001\/jama.289.1.76"},{"key":"2021120820051287600_R45","unstructured":"Wright JD, Bialostosky K, Gunter EW, et al. Blood folate and vitamin B12: United States, 1988\u201394. Vital Health Stat 11.\u20081998;1\u201378"},{"key":"2021120820051287600_R46","doi-asserted-by":"crossref","unstructured":"Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology.\u20081995;6:219\u2013226","DOI":"10.1097\/00001648-199505000-00005"},{"key":"2021120820051287600_R47","doi-asserted-by":"crossref","unstructured":"Suarez L, Hendricks KA, Cooper SP, Sweeney AM, Hardy RJ, Larsen RD. Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate. Am J Epidemiol.\u20082000;152:1017\u20131023","DOI":"10.1093\/aje\/152.11.1017"},{"key":"2021120820051287600_R48","doi-asserted-by":"crossref","unstructured":"Hertrampf E, Cortes F. Folic acid fortification of wheat flour: Chile. Nutr Rev.\u20082004;62:S44\u2013S48","DOI":"10.1111\/j.1753-4887.2004.tb00074.x"},{"key":"2021120820051287600_R49","doi-asserted-by":"crossref","unstructured":"Martinez de Villarreal L, Perez JZ, et al. Decline of neural tube defects cases after a folic acid campaign in Nuevo Leon, Mexico. Teratology.\u20082002;66:249\u2013256","DOI":"10.1002\/tera.10094"},{"key":"2021120820051287600_R50","doi-asserted-by":"crossref","unstructured":"Chen LT, Rivera MA. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr Rev.\u20082004;62:S40\u2013S43","DOI":"10.1111\/j.1753-4887.2004.tb00073.x"},{"key":"2021120820051287600_R51","doi-asserted-by":"crossref","unstructured":"Baker D, Teklehaimanot S, Hassan R, Guze C. A look at a Hispanic and African American population in an urban prenatal diagnostic center: referral reasons, amniocentesis acceptance, and abnormalities detected. Genet Med.\u20082004;6:211\u2013218","DOI":"10.1097\/01.GIM.0000132684.94642.A0"},{"key":"2021120820051287600_R52","doi-asserted-by":"crossref","unstructured":"Peller AJ, Westgate MN, Holmes LB. Trends in congenital malformations, 1974\u20131999: effect of prenatal diagnosis and elective termination. Obstet Gynecol.\u20082004;104:957\u2013964","DOI":"10.1097\/01.AOG.0000142718.53380.8f"},{"key":"2021120820051287600_R53","doi-asserted-by":"crossref","unstructured":"Siffel C, Correa A, Cragan JD, Alverson CJ. Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta. Birth Defects Res A Clin Mol Teratol.\u20082004;70:565\u2013571","DOI":"10.1002\/bdra.20064"},{"key":"2021120820051287600_R54","unstructured":"Tumiel LM, Buck GM, Zayas LE, Jaen CR. Unmasking adverse birth outcomes among Hispanic subgroups. Ethn Dis.\u20081998;8:209\u2013217"},{"key":"2021120820051287600_R55","doi-asserted-by":"crossref","unstructured":"Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep.\u20082001;116(suppl 1):32\u201340","DOI":"10.1093\/phr\/116.S1.32"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/3\/580\/1005227\/zpe00905000580.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/3\/580\/1005227\/zpe00905000580.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T09:59:30Z","timestamp":1706522370000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/3\/580\/68437\/Decline-in-the-Prevalence-of-Spina-Bifida-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,9,1]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-0592","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]}}}